Ospedale San Raffaele SRL

Ospedale San Raffaele SRL is a company in Milano, Italy that has taken part in 148 EU-funded projects since 2008, receiving €68.8M in EU funding and leading 52 as coordinator.

EU funding received€68.8M
EU projects148
As coordinator52
Running now40
First EU project2008
Latest project2027
CountryItaly
EU registration (PIC)953176030
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Ospedale San Raffaele SRL's own share of each project, not the project's full budget.

  • Horizon 2020€32.8M · 77 projects
  • Horizon Europe€26.1M · 44 projects
  • FP7 (2007 to 2013)€9.2M · 20 projects
  • EU4Health Programme (EU4H)€268k · 5 projects
  • Interregional Innovation Investments Instrument (I3)€261k · 1 project
  • 3rd Health Programme€222k · 1 project

Projects

148 EU-funded projects, newest first. Ospedale San Raffaele SRL led 52 of them as coordinator. Each links to the official record.

  • TTRAILAssociated partner

    Transferable Trustworthy Radiotherapy with Artificial Intelligence

    Horizon Europe · 2027–2031 · Project on CORDIS ↗

  • QrCiliopathiesCoordinator

    Targeting Glutamine (Q) Metabolism in the Renal Ciliopathies

    Horizon Europe · 2026–2028 · Project on CORDIS ↗

    €150ktheir share
  • IAM-CCPartner

    A Competence Centre to assess and advance societal readiness towards adoption of Innovative Air Mobility solutions to increase social welfare

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

    €324ktheir share
  • MINerVACoordinator

    Unlocking the neurovascular interface of peripheral nerves in homeostasis, disease and repair

    Horizon Europe · 2026–2032 · Project on CORDIS ↗

    €2.5Mtheir share
  • VISI-ON-BRAINAssociated partner

    CUTTING-EDGE HUMAN IN VITRO AND IN SILICO BIOMEDICAL TOOLS ON BRAIN DISORDERS

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

  • EX-DR TBPartner

    EX-DR TB: Elimination of Extensive Drug Resistance Through better Regimens for TB

    Horizon Europe · 2025–2031 · Project on CORDIS ↗

    €324ktheir share
  • TRANSCENDAssociated partner

    Transcending limitations of translational research on Multiple Sclerosis and Autism Spectrum Disorder - Spectral, brain-related disorder, patient outcomes, cognition, effect, symptoms

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

  • ENRICHING-HDRCoordinator

    Enriching HDR edits for enhancing efficacy and precision of HSPC gene therapy

    Horizon Europe · 2025–2027 · Project on CORDIS ↗

    €209ktheir share
  • UniCardioMabCoordinator

    Universal Cardiac Mesoangioblasts for treating DMD Dilated Cardiomyopathy

    Horizon Europe · 2025–2026 · Project on CORDIS ↗

    €115ktheir share
  • ResolVE-XASCoordinator

    Addressing Unknowns and Unmet Needs of VEXAS Syndrome by Multiomics Clonal Tracking and Targeted Gene Editing

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

    €1.5Mtheir share
  • TalesfromDeathCoordinator

    Dissect the impact, safety and effectiveness of gene therapy at the whole organismal level by cell-free DNA signatures

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

    €2.0Mtheir share
  • LAMA2-TFIMGCoordinator

    Tackling fibrosis and inflammation in LAMA2-RD by in vivo modulation of a novel modifier gene

    Horizon Europe · 2025–2026 · Project on CORDIS ↗

    €173ktheir share
  • IDENTIKITAssociated partner

    IDENTIfication and tracking of cancer-prone cells in KIdney Tubules

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

  • UNIONPartner

    UnderstandiNg fraIlty tOwards a future of healthy ageiNg

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

    €259ktheir share
  • MIRACLEPartner

    Integrated multi-angle research and training network to eradicate leukemia minimal residual disease

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €259ktheir share
  • QtCiliaCoordinator

    A Novel Glutamine (Q) Sensory Role for Primary Cilia: Implications for Health and Disease

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

    €2.5Mtheir share
  • EUnetCCC JAAssociated partner

    The European Comprehensive Cancer Centre Network

    EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗

    €112ktheir share
  • ERDERAPartner

    EUROPEAN RARE DISEASES RESEARCH ALLIANCE

    Horizon Europe · 2024–2031 · Project on CORDIS ↗

    €314ktheir share
  • B-PathPartner

    Breath Pathogen Detection (B-Path): Establishing Exhaled Breath Aerosol (XBA) sampling for diagnosis and screening of respiratory infections

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €722ktheir share
  • BAN-BOOTAssociated partner

    Boronic Acids as a New Strategy to Boost beta-Lactam Antibiotics for the Treatment of Tubercolosis

    Horizon Europe · 2024–2026 · Project on CORDIS ↗

  • MOD-REGCoordinator

    Modulating Tregs in liver disease for therapeutic benefit

    Horizon Europe · 2024–2026 · Project on CORDIS ↗

    €189ktheir share
  • PolArtPartner

    Neuromorphic Polariton Accelerator

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €144ktheir share
  • BreathForDxPartner

    Establishing Exhaled Breath Aerosol (XBA) sampling for diagnosis and screening of respiratory infections

    Horizon Europe · 2024–2026 · Project on CORDIS ↗

    €486ktheir share
  • IMMERGEPartner

    Storming Immune Monogenic Conditions through Multiomic and Gene Editing Approaches

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

    €259ktheir share
  • ENDEAVORPartner

    Endoscopic brush cytology and single cell clinal dynamics of early easophageal adenocarcinoma for detecting cost effective surveillance strategies and prediction of cancer recurrence

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €411ktheir share
  • EU-JAMRAI 2Associated partner

    Joint Action Antimicrobial Resistance and Healthcare-Associated Infections 2

    EU4Health Programme (EU4H) · 2024–2027 · Project on the EU portal ↗

    €38ktheir share
  • EDENT1FIPartner

    European action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease Interception

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €361ktheir share
  • DigiONE I3Partner

    DIGItal Infrastructure for ONcology in Europe

    Interregional Innovation Investments Instrument (I3) · 2023–2026 · Project on the EU portal ↗

    €261ktheir share
  • S-CAMCoordinator

    Spirocyclic CAMs as novel and ultrapotent anti-HBV drugs (S-CAM)

    Horizon Europe · 2023–2025 · Project on CORDIS ↗

    €150ktheir share
  • MEFHISTOAssociated partner

    Decoding and targeting the PGE2-MEF2A axis in tumor-associated macrophages

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

  • PHIRECoordinator

    Photoacoustic imaging and artificial intelligence-based theranostic approach for cancer

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €701ktheir share
  • MABankCoordinator

    Creation of a GLP bank of immune-privileged, immortal mesoangioblasts to treat monogenic, recessive diseases of muscle and connective tissue

    Horizon Europe · 2023–2025 · Project on CORDIS ↗

    €115ktheir share
  • TheRaCilPartner

    Therapies for Renal Ciliopathies

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €339ktheir share
  • IMMUTOLAssociated partner

    ADVANCED ANTIGEN-SPECIFIC DENDRITIC CELL-BASED THERAPY TO RE-ESTABLISH TOLERANCE IN IMMUNE-MEDIATED DISEASES

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

  • RESTORE VISIONPartner

    Novel advanced and repurposed therapeutics for vision restoration in a group of severe rare ocular surface diseases: from validation to first clinical investigations

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €1.5Mtheir share
  • DEGLYCAR-TCoordinator

    Engineering CAR-T cells to overcome glycosylation-driven tumour resistance

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €1.5Mtheir share
  • HSC-reNEWCoordinator

    Dissecting the molecular regulation of hematopoietic stem cell emergence using pluripotent stem cells to improve ex vivo therapies

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €2.0Mtheir share
  • REGENERATE-ITPartner

    Learning from animals how to regenerate: multidisciplinary training programme in regenerative biology

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €259ktheir share
  • NEMECYSPartner

    NEw MEdical CYbersecurity assessment and design Solutions

    Horizon Europe · 2023–2025 · Project on CORDIS ↗

    €316ktheir share
  • HappyMumsPartner

    Understanding, predicting, and treating depression in pregnancy to improve mothers and offspring mental health outcomes

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €651ktheir share
Show 40 more projects
  • VH-COMSAVACPartner

    Multi-country Viral Hepatitis COMmunity Screening, Vaccination, and Care

    EU4Health Programme (EU4H) · 2022–2025 · Project on the EU portal ↗

  • CAN.HEALAssociated partner

    Building the EU Cancer and Public Health Genomics platform

    EU4Health Programme (EU4H) · 2022–2025 · Project on the EU portal ↗

    €33ktheir share
  • X-PANDCoordinator

    Exploiting ex vivo expansion and deep multiomics profiling to bring novel, efficient and safer hematopoietic stem cell gene therapies to clinical application

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €1.7Mtheir share
  • eCANAssociated partner

    Joint Action on strengthening ehealth including telemedicine and remote monitoring for health care systems for cancer prevention and care

    EU4Health Programme (EU4H) · 2022–2024 · Project on the EU portal ↗

    €85ktheir share
  • 4-DBRPartner

    4-Deep Brain Reconstruction

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €510ktheir share
  • EPIVINFPartner

    Epigenetic regulation of host factors in viral infections (EPIVINF)

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €1.0Mtheir share
  • EDITSCDPartner

    Assessing efficacy and safety of genome EDITing approaches for Sickle Cell Disease

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €1.0Mtheir share
  • UNDINEPartner

    The human genetic and immunological determinants of the clinical manifestations of SARS-CoV-2 infection: Towards personalised medicine

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €300ktheir share
  • CINDERELLAPartner

    Clinical Validation of an AI-based approach to improve the shared decision-making process and outcomes in Breast Cancer Patients proposed for Locoregional treatment

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €681ktheir share
  • KATSIMPartner

    Cataract Simulator Diagnostics Device Development Using Computational Holographic Displays

    Horizon Europe · 2022–2025 · Project on CORDIS ↗

    €163ktheir share
  • ReviveSTEMCoordinator

    Dissecting and targeting senescence programs to advance Hematopoietic Stem Cell-based gene therapies

    Horizon 2020 · 2022–2028 · Project on CORDIS ↗

    €2.0Mtheir share
  • IMPROVING-GTCoordinator

    Innovative strategies to increase engraftment of engineered hematopoietic stem cells and bypass genotoxic conditioning, toward the next-generation gene therapy

    Horizon 2020 · 2022–2023 · Project on CORDIS ↗

    €183ktheir share
  • ComBATageingCoordinator

    Exploiting superlongevous model mammals to explore new links between protein and organelle homeostasis and lifespan extension

    Horizon 2020 · 2021–2023 · Project on CORDIS ↗

    €183ktheir share
  • Algae4IBDPartner

    ALGAE4IBD –FROM NATURE TO BEDSIDE- ALGAE BASED BIO COMPOUND FOR PREVENTION AND TREATMENT OF INFLAMMATION, PAIN AND IBD

    Horizon 2020 · 2021–2026 · Project on CORDIS ↗

    €415ktheir share
  • BRAINeSsCoordinator

    Short-chain fatty acids in brain neuroinflammation: modulators of immunity and neural stemness

    Horizon 2020 · 2021–2023 · Project on CORDIS ↗

    €183ktheir share
  • INCITEPartner

    Immune Niches for Cancer ImmunoTherapy Enhancement

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €830ktheir share
  • AIR3DPartner

    Minimum viable product for automated 3D imaging reconstruction of the bladder and the bladder cancer

    Horizon 2020 · 2021–2022 · Project on CORDIS ↗

    €20ktheir share
  • DREAMCoordinator

    Dux4-Regulated Expression and Activity by an inhibitor Molecule

    Horizon 2020 · 2021–2023 · Project on CORDIS ↗

    €183ktheir share
  • ARTERYPartner

    Autonomous Robotics for Transcatheter dEliveRy sYstems

    Horizon 2020 · 2021–2024 · Project on CORDIS ↗

    €329ktheir share
  • UniMabCoordinator

    Immune-privileged, immortal, myogenic stem cells for gene therapy of Muscular Dystrophy.

    Horizon 2020 · 2021–2026 · Project on CORDIS ↗

    €2.3Mtheir share
  • FF2020Partner

    Creating the 21st century spatial ecosystem

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €339ktheir share
  • RENergeticPartner

    Community-empowered Sustainable Multi-Vector Energy Islands

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €237ktheir share
  • AXONENDOCoordinator

    Endosomal control of local protein synthesis in axons

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

    €1.5Mtheir share
  • PHASTPartner

    Photonics for Healthcare: multiscAle cancer diagnosiS and Therapy

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

    €262ktheir share
  • SoMuKTCoordinator

    SOmatic MUtagenesis in Kidney Tubule is enhanced by specific metabolic pathways

    Horizon 2020 · 2020–2022 · Project on CORDIS ↗

    €183ktheir share
  • ASTRO-EDITINGCoordinator

    Targeting ASTROcytes with cutting-edge EDITING technologies to treat the Alexander disease

    Horizon 2020 · 2020–2022 · Project on CORDIS ↗

    €183ktheir share
  • 2LIVErCoordinator

    IL-2 gene therapy for chronic hepatitis B virus infection

    Horizon 2020 · 2020–2022 · Project on CORDIS ↗

    €150ktheir share
  • B1MGAssociated partner

    Beyond 1M Genomes

    Horizon 2020 · 2020–2023 · Project on CORDIS ↗

  • IDEALCoordinator

    Inhibitor of DUX4-IGH to Erase Acute lymphoblastic Leukaemia

    Horizon 2020 · 2020–2022 · Project on CORDIS ↗

    €171ktheir share
  • RECOGNISEDPartner

    Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €589ktheir share
  • INsTRuCTPartner

    INnovative Training in Myeloid Regulatory Cell Therapy

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €262ktheir share
  • SCilSPartner

    Studying Ciliary Signaling in Development and Disease

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €262ktheir share
  • EATRIS-PlusAssociated partner

    Consolidating the capacities of EATRIS-ERIC for Personalised Medicine

    Horizon 2020 · 2020–2023 · Project on CORDIS ↗

  • VANGUARDPartner

    New Generation Cell Therapy: Bioartificial Pancreas to Cure Type 1 Diabetes

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

    €1.0Mtheir share
  • ESPACEPartner

    Human Cell Atlas of the Pancreas

    Horizon 2020 · 2020–2022 · Project on CORDIS ↗

    €296ktheir share
  • HI_IM_NEUROSOCIETYCoordinator

    HIstory and IMpact of NEUROimaging on SOCIETY

    Horizon 2020 · 2019–2021 · Project on CORDIS ↗

    €168ktheir share
  • SMART BEARAssociated partner

    Smart Big Data Platform to Offer Evidence-based Personalised Support for Healthy and Independent Living at Home

    Horizon 2020 · 2019–2025 · Project on CORDIS ↗

  • BrainCircuit-on-chipCoordinator

    Microfluidic chambers for establishing physiological and pathological human iPSC-derived neuronal circuits

    Horizon 2020 · 2019–2021 · Project on CORDIS ↗

    €100ktheir share
  • RTTOPHAGYCoordinator

    "Investigating autophagy enhancement as a therapeutic approach for the treatment of Rett syndrome.""""

    Horizon 2020 · 2019–2021 · Project on CORDIS ↗

    €171ktheir share
  • DADA2GTCoordinator

    Development of gene therapy and genome editing strategies to treat adenosine deaminase 2 deficiency

    Horizon 2020 · 2019–2021 · Project on CORDIS ↗

    €183ktheir share

Showing the 80 most recent of 148 projects.

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • 5G
  • DNA
  • HIV
  • RNA
  • access control
  • additive manufacturing
  • aeronautical engineering
  • air pollution engineering
  • alkaline earth metals
  • alzheimer
  • amines
  • amorphous solids
  • anatomy and morphology
  • antibiotics

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime